| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | WIPO (World Intellectual Property Organization) | 6 | |
| #3 | Australia | 5 | |
| #4 | EPO (European Patent Office) | 4 | |
| #5 | Republic of Korea | 3 | |
| #6 | Canada | 2 | |
| #7 | China | 2 | |
| #8 | Mexico | 2 | |
| #9 | Hungary | 1 | |
| #10 | Israel | 1 | |
| #11 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lim Ai Ching | 13 |
| #2 | Escobar Sabine S | 13 |
| #3 | Narayanan Saravanakumar | 13 |
| #4 | King Chadwick T | 13 |
| #5 | Arnett Heather A | 13 |
| #6 | Pederson Nels E | 12 |
| #7 | Weinreb Paul H | 12 |
| #8 | Gandhi Rohan | 10 |
| #9 | Paolini John | 10 |
| #10 | Shahrokh Zahra | 9 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020247521A1 | Treatment of cancers with gm-csf antagonists | |
| WO2020097321A1 | Treatment for giant cell arteritis | |
| WO2020036833A1 | Treatment of skin diseases or disorders by delivery of anti-osmrbeta antibody | |
| WO2020096664A1 | Treatment for giant cell arteritis | |
| WO2019229525A2 | TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRβ ANTIBODY | |
| EP3609916A1 | Stable anti-osmr antibody formulation | |
| MX2015016304A | Oncostatin m receptor antigen binding proteins. |